Abeona Therapeutics (ABEO)

Abeona Therapeutics (ABEO) Stock Price & Analysis


ABEO Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$2.19 - $9.35
Previous Close$2.78
Average Volume (3M)199.12K
Market Cap
Enterprise Value$36.85M
Total Cash (Recent Filing)$18.17M
Total Debt (Recent Filing)$8.29M
Price to Earnings (P/E)-0.2
May 12, 2023
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-17.64
Shares Outstanding17,175,799
10 Day Avg. Volume140,926
30 Day Avg. Volume199,119
Standard Deviation0.25
Financial Highlights & Ratios
Price to Book (P/B)3.02
Price to Sales (P/S)35.48
Price to Cash Flow (P/CF)30.00
P/FCF Ratio-1.60
Enterprise Value/Market CapN/A
Enterprise Value/Revenue8.48
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-0.46
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Abeona Therapeutics’s price range in the past 12 months?
Abeona Therapeutics lowest stock price was $2.19 and its highest was $9.35 in the past 12 months.
    What is Abeona Therapeutics’s market cap?
    Currently, no data Available
    When is Abeona Therapeutics’s upcoming earnings report date?
    Abeona Therapeutics’s upcoming earnings report date is May 12, 2023 which is in 44 days.
      How were Abeona Therapeutics’s earnings last quarter?
      Currently, no data Available
      Is Abeona Therapeutics overvalued?
      According to Wall Street analysts Abeona Therapeutics’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Abeona Therapeutics pay dividends?
        Abeona Therapeutics does not currently pay dividends.
        What is Abeona Therapeutics’s EPS estimate?
        Abeona Therapeutics’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Abeona Therapeutics have?
        Abeona Therapeutics has 17,175,798 shares outstanding.
          What happened to Abeona Therapeutics’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Abeona Therapeutics?
          Among the largest hedge funds holding Abeona Therapeutics’s share is Deerfield Management Company, LP. It holds Abeona Therapeutics’s shares valued at 3M.


            Abeona Therapeutics Stock Smart Score

            The Abeona Therapeutics stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
            Learn more about TipRanks Smart Score

            Company Description

            Abeona Therapeutics

            Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB); ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA) and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). The company was founded in 1974 and is headquartered in New York, NY.


            Top 5 ETFs holding ABEO

            Currently, no data available
            Please return soon. This page is being updated.
            Up to five ETFs with an Outperform Smart Score that hold ABEO. The ETFs are listed according to market value of ABEO within the ETF


            Forecast EPS vs Actual EPS

            Currently, no data available
            Please return soon. This page is being updated.

            Similar Stocks
            Price & Change
            Xilio Therapeutics
            Adverum Biotechnologies
            Axcella Health
            Magenta Therapeutics

            Popular Stocks

            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis